ASTRAZENECA PHARMACEUTICALS LP et al v. NATCO PHARMA LIMITED et al > Summary
Court Case Number 3:23-cv-00796
Filing Date Feb 10, 2023
Court New Jersey District Court
Status Unknown
JudgesRobert Kirsch
Plaintiff
5Defendant
Plaintiff Attorneys
5AstraZeneca
Attorney Name: Charles H. Chevalier
Gibbons P.C.
AstraZeneca
Attorney Name: David I. Berl
Williams & Connolly
AstraZeneca
Attorney Name: Kevin D. Hoagland-Hanson
Williams & Connolly
AstraZeneca
Attorney Name: Rebecca A. Carter
Williams & Connolly
AstraZeneca
Attorney Name: Elise M. Baumgarten
Williams & Connolly
Defendant Attorneys
5Natco Pharma Ltd.
Attorney Name: James Richter
Midlige Richter
Natco Pharma Ltd.
Attorney Name: William A. Rakoczy
Rakoczy Molino Mazzochi Siwik
Natco Pharma Ltd.
Attorney Name: Paul John Molino
Rakoczy Molino Mazzochi Siwik
Natco Pharma Ltd.
Attorney Name: Kevin E. Warner
Rakoczy Molino Mazzochi Siwik
Natco Pharma Ltd.
Attorney Name: Greg L. Goldblatt
Rakoczy Molino Mazzochi Siwik
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08859562 | Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer | Oct 14, 2014 |
| 08475842 | Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one | Jul 2, 2013 |
| 07449464 | Phthalazinone derivatives | Nov 11, 2008 |
